High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014

Patient With Coronary Stents Needs Surgery

(2013) Emmanouil S. Brilakis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of Fluid Resuscitation With Colloids vs Crystalloids on Mortality in Critically Ill Patients Presenting With Hypovolemic Shock

(2013) Djillali Annane   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents

(2013) Mary T. Hawn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Phase II Study of Bevacizumab and High-dose Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma

(2013) Uday B. Dandamudi et al.   JOURNAL OF IMMUNOTHERAPY

Resuscitation Fluids

(2013) John A. Myburgh et al.   NEW ENGLAND JOURNAL OF MEDICINE

The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses

(2012) Brendon Coventry et al.   Cancer Management and Research

Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma

(2010) Steven E. Finkelstein et al.   JOURNAL OF IMMUNOTHERAPY

Novel Management of Pruritus in Patients Treated With IL-2 for Metastatic Renal Cell Carcinoma and Malignant Melanoma

(2010) Sung Ho Lee et al.   JOURNAL OF IMMUNOTHERAPY

Transient Cytokine-Induced Liver Injury Following Administration of the Humanized Anti-CD3 Antibody Visilizumab (HuM291) in Crohn's Disease

(2009) Daniel C Baumgart et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Toxicity and Activity of a Twice Daily High-dose Bolus Interleukin 2 Regimen in Patients With Metastatic Melanoma and Metastatic Renal Cell Cancer

(2009) Nicolas Acquavella et al.   JOURNAL OF IMMUNOTHERAPY

Retrospective Analysis of the Safety and Efficacy of Interleukin-2 After Prior VEGF-targeted Therapy in Patients With Advanced Renal Cell Carcinoma

(2009) Daniel C. Cho et al.   JOURNAL OF IMMUNOTHERAPY